Sight Sciences, Inc. SGHT
8.93
0.25
2.88%
as of 25 Sep
- Market cap
- $478.2M
- P/E
- 0.0×
Follow SGHT
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (48.42%) | (56.64%) | (50.74%) | (57.91%) |
+8 more TTM periods Free account |
|
| (26.24%) | (31.12%) | (29.77%) | (35.49%) | ||
ROIC |
(125.18%) | (235.20%) | (188.86%) | (236.53%) | |
Return on Tangible Assets |
(36.02%) | (41.41%) | (37.19%) | (44.63%) | |
Average Days of Receivables |
49.84 | 48.61 | 45.98 | 46.76 | |
Free Cash Flow per Share |
(0.43) | (0.47) | (0.58) | (0.61) | |
Free Cash Flow |
(23.33) | (25.40) | (30.05) | (31.89) | |
Capital Expenditures |
(0.09) | (0.28) | (0.36) | (0.57) | |
Piotroski F-Score |
4.00 | 4.00 | 5.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(13.40%) | (14.00%) | (15.13%) | (15.92%) | |
Accounts Receivable Turnover |
7.94 | 7.95 | 7.54 | 6.71 | |
Accounts Payable Turnover |
5.05 | 5.18 | 7.05 | 6.98 | |
Inventory Turnover |
1.69 | 1.72 | 1.52 | 1.51 | |
Average Days of Payables |
69.00 | 49.29 | 45.83 | 59.91 | |
Days of Inventory on Hand |
207.04 | 232.44 | 265.02 | 274.58 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
13.01% | 15.99% | 18.88% | 21.65% | |
Selling, General and Administrative Expense of Revenue |
108.38% | 114.99% | 115.25% | 124.04% | |
Share Based Compensation of Revenue |
12.94% | 14.66% | 16.87% | 19.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 0.67 | 0.77 | 0.68 | |
Depreciation/Fixed assets |
0.82 | 0.86 | 0.89 | 0.95 | |
Capex/Depreciation |
(0.07) | (0.20) | (0.25) | (0.39) | |
Revenue per Share |
1.53 | 1.47 | 1.48 | 1.45 | |
Operating CF per Share |
(0.43) | (0.47) | (0.57) | (0.60) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Net Profit Margin |
(35.69%) | (46.83%) | (49.67%) | (60.63%) |
Columns are period end dates